| 摘要 |
The present invention relates to a composition comprising polyclonal antibodies directed against human cells, wherein the said polyclonal antibodies are devoid of a first antigenic determinant selected in a group comprising (i) N-glycolneuraminic acid (Neu5Gc) and (ii) α-1,3-galactose and its use as a medicament |
